Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium isotope |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium/sodium ratio measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium adverse reaction |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
Oral potassium adverse reaction |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
Parenteral potassium adverse reaction |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
Potassium overdose |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
Accidental potassium overdose |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
Intentional potassium overdose |
Causative agent |
True |
Potassium |
Inferred relationship |
Some |
1 |
overdosis af kalium, uvist med hvilken hensigt |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
1 |
Potassium measurement, urine |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
forgiftning med kalium |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
1 |
Fluid sample potassium measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Serum potassium measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Blood potassium measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
24 hour urine potassium output measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Sweat potassium measurement |
Has measured component |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium chloride |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium gluconate |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium/sodium ratio measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Potassium measurement, urine |
Component |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
Fluid sample potassium measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Serum potassium measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Blood potassium measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
24 hour urine potassium output measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
|
Sweat potassium measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
allergi over for kalium til topikal anvendelse |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
|
allergi over for kalium |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
|
allergi over for kalium til oral anvendelse |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
|
allergi over for kalium til parenteral anvendelse |
Causative agent |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium brusetabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogencarbonat + kaliumchlorid brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumphosphat injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumphosphat 2 mmol/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumphosphat 2 mmol/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenphosphat injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenphosphat 1 mmol/ml injektionsvæske, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumascorbat øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol + natriumchlorid 0,9 % infusionsvæske, opløsning i pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumklorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium 6,5 mmol brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium i saltvand til infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium + glucose infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium + glucose/saltvand infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium til topisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 %/natriumchloridd 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely potassium perchlorate 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumnitrat 8 % pasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely monobasic potassium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumiodid 5 g/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium supplement (substance) |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium citrate (substance) |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
Plasma potassium level (procedure) |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Potassium electrolyte |
Is a |
True |
Potassium |
Inferred relationship |
Some |
|
Kaliumtilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
diuretika med kalium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
bendrofluazid 2,5 mg + kalium 7,7 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
frusemid 40 mg + kalium 8 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
frusemid 20 mg + kalium 10 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
bendrofluazid 2,5 mg + kalium 8,4 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumtilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 8 mg + kaliumiodid 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing furosemide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing bumetanide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
Product containing bendroflumethiazide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
Product containing potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumnitrat 5 % pasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenkarbonat 1,39 g + citronsyre 1,14 g opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Citric acid + potassium bicarbonate 2ns/2.5ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Measurement of fractional excretion of potassium (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
Ringer-laktat, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium measurement, urine |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
24 hour urine potassium output measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |